AAPL 206.655 1.0044% MSFT 384.86 2.7965% NVDA 106.185 3.3833% GOOGL 158.72 2.1693% GOOG 160.73 1.9084% AMZN 185.5673 2.7504% META 530.91 2.0451% AVGO 187.43 5.9465% BRK-A 795500.0 0.8495% BRK-B 530.135 0.6312% LLY 855.05 3.0901% TSLA 255.535 1.9123% TSM 163.78 3.783% V 336.305 0.5787% JPM 243.935 1.2683% UNH 426.3 -0.3879% NVO 62.61 2.137% WMT 95.78 0.8635% LVMUY 113.69 1.6632% XOM 108.77 1.3039%
Last update at 2025-04-23T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | -181.00000M | 1.00M | -83.00000M | -25.00000M | 19.00M |
Minority interest | 2.00M | -4.00000M | 51.00M | 47.00M | 38.00M |
Net income | -221.00000M | -17.00000M | 613.00M | -53.00000M | -24.00000M |
Selling general administrative | 182.00M | 155.00M | 144.00M | 176.00M | 172.00M |
Selling and marketing expenses | 249.00M | 231.00M | 223.00M | 299.00M | 321.00M |
Gross profit | 528.00M | 497.00M | 494.00M | 729.00M | 714.00M |
Reconciled depreciation | 63.00M | 62.00M | 69.00M | 94.00M | 60.00M |
Ebit | -82.00000M | 29.00M | 23.00M | 40.00M | 77.00M |
Ebitda | -19.00000M | 91.00M | 92.00M | 134.00M | 137.00M |
Depreciation and amortization | 63.00M | 62.00M | 69.00M | 94.00M | 60.00M |
Non operating income net other | - | - | - | - | 0.00000M |
Operating income | -160.00000M | 9.00M | -52.00000M | 14.00M | 59.00M |
Other operating expenses | 1867.00M | 1740.00M | 1682.00M | 2131.00M | 2177.00M |
Interest expense | 20.00M | 14.00M | 28.00M | 42.00M | 41.00M |
Tax provision | 42.00M | 15.00M | 15.00M | 28.00M | 34.00M |
Interest income | 11.00M | 8.00M | 8.00M | 11.00M | 8.00M |
Net interest income | -12.00000M | -6.00000M | -23.00000M | -34.00000M | -32.00000M |
Extraordinary items | - | - | - | - | 0.00000M |
Non recurring | - | - | - | - | 0.00000M |
Other items | - | - | - | - | 0.00000M |
Income tax expense | 42.00M | 15.00M | 15.00M | 28.00M | 34.00M |
Total revenue | 1857.00M | 1760.00M | 1709.00M | 2239.00M | 2247.00M |
Total operating expenses | 538.00M | 477.00M | 467.00M | 621.00M | 644.00M |
Cost of revenue | 1329.00M | 1263.00M | 1215.00M | 1510.00M | 1533.00M |
Total other income expense net | -21.00000M | -8.00000M | -31.00000M | -39.00000M | -40.00000M |
Discontinued operations | - | - | 719.00M | 36.00M | -3.00000M |
Net income from continuing ops | -223.00000M | -14.00000M | -98.00000M | -53.00000M | -15.00000M |
Net income applicable to common shares | -221.00000M | -17.00000M | 613.00M | -53.00000M | -24.00000M |
Preferred stock and other adjustments | - | - | - | - | 0.00000M |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 1368.00M | 1756.00M | 2095.00M | 2204.00M | 2294.00M |
Intangible assets | 24.00M | 29.00M | 12.00M | 18.00M | 76.00M |
Earning assets | - | - | - | - | - |
Other current assets | 130.00M | 14.00M | 15.00M | 13.00M | 19.00M |
Total liab | 972.00M | 1195.00M | 1409.00M | 1583.00M | 2164.00M |
Total stockholder equity | 395.00M | 520.00M | 632.00M | 570.00M | 83.00M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 219.00M | 3.00M | -1.00000M | 1.00M | 427.00M |
Common stock | 187.00M | 187.00M | 187.00M | 187.00M | 187.00M |
Capital stock | 187.00M | 187.00M | 187.00M | 187.00M | 187.00M |
Retained earnings | 945.00M | 1042.00M | 1284.00M | 1412.00M | 803.00M |
Other liab | - | 569.00M | 766.00M | 991.00M | 1178.00M |
Good will | 215.00M | 219.00M | 280.00M | 265.00M | 492.00M |
Other assets | -30.00000M | 1.00M | 257.00M | 218.00M | 230.00M |
Cash | 77.00M | 138.00M | 398.00M | 585.00M | 107.00M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 388.00M | 585.00M | 597.00M | 538.00M | 761.00M |
Current deferred revenue | 97.00M | 309.00M | 319.00M | 311.00M | - |
Net debt | 6.00M | -73.00000M | -325.00000M | -503.00000M | 219.00M |
Short term debt | 14.00M | 24.00M | 27.00M | 28.00M | 102.00M |
Short long term debt | 0.00000M | 4.00M | 3.00M | 3.00M | 65.00M |
Short long term debt total | 83.00M | 65.00M | 73.00M | 82.00M | 326.00M |
Other stockholder equity | -737.00000M | -709.00000M | -839.00000M | -1029.00000M | -907.00000M |
Property plant equipment | - | 152.00M | 197.00M | 205.00M | 252.00M |
Total current assets | 792.00M | 1153.00M | 1339.00M | 1490.00M | 1234.00M |
Long term investments | - | - | - | - | 12.00M |
Net tangible assets | - | 273.00M | 339.00M | 286.00M | -483.00000M |
Short term investments | 71.00M | 1.00M | 2.00M | 9.00M | -100.00000M |
Net receivables | 296.00M | 513.00M | 506.00M | 494.00M | 672.00M |
Long term debt | 39.00M | -1.00000M | -1.00000M | 0.00000M | 149.00M |
Inventory | 289.00M | 487.00M | 418.00M | 389.00M | 436.00M |
Accounts payable | 132.00M | 249.00M | 252.00M | 198.00M | 232.00M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -948.00000M | - | - | - | - |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | - |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 148.00M | 108.00M | 134.00M | 108.00M | 2.00M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 576.00M | 602.00M | 756.00M | 714.00M | 1060.00M |
Capital lease obligations | 43.00M | 62.00M | 71.00M | 79.00M | 112.00M |
Long term debt total | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | -76.00000M | -2.00000M | 892.00M | 1.00M | 1.00M |
Change to liabilities | -15.00000M | 41.00M | 25.00M | 6.00M | 21.00M |
Total cashflows from investing activities | -76.00000M | -2.00000M | 892.00M | -28.00000M | -57.00000M |
Net borrowings | -31.00000M | -30.00000M | -234.00000M | -116.00000M | 192.00M |
Total cash from financing activities | -77.00000M | -67.00000M | -249.00000M | -131.00000M | 175.00M |
Change to operating activities | -174.00000M | -296.00000M | -428.00000M | -253.00000M | -274.00000M |
Net income | -223.00000M | -14.00000M | 621.00M | -48.00000M | -15.00000M |
Change in cash | -260.00000M | -187.00000M | 486.00M | -37.00000M | 69.00M |
Begin period cash flow | 398.00M | 585.00M | 99.00M | 136.00M | 67.00M |
End period cash flow | 138.00M | 398.00M | 585.00M | 99.00M | 136.00M |
Total cash from operating activities | -100.00000M | -116.00000M | -153.00000M | 123.00M | -44.00000M |
Issuance of capital stock | - | - | - | - | - |
Depreciation | 63.00M | 62.00M | 69.00M | 94.00M | 60.00M |
Other cashflows from investing activities | 4.00M | 4.00M | 917.00M | 18.00M | 3.00M |
Dividends paid | - | - | - | - | 0.00000M |
Change to inventory | -65.00000M | -48.00000M | 25.00M | 50.00M | -57.00000M |
Change to account receivables | 11.00M | -2.00000M | 40.00M | 11.00M | -4.00000M |
Sale purchase of stock | -21.00000M | -29.00000M | - | - | 0.00000M |
Other cashflows from financing activities | -52.00000M | -35.00000M | 10.00M | 70.00M | 209.00M |
Change to netincome | 301.00M | 144.00M | -497.00000M | 268.00M | 240.00M |
Capital expenditures | 33.00M | 26.00M | 33.00M | 38.00M | 40.00M |
Change receivables | - | - | - | - | 0.00000M |
Cash flows other operating | - | - | - | - | 0.00000M |
Exchange rate changes | - | - | - | - | 0.00000M |
Cash and cash equivalents changes | - | - | - | - | 0.00000M |
Change in working capital | -67.00000M | 7.00M | 102.00M | 76.00M | -80.00000M |
Stock based compensation | - | - | - | - | - |
Other non cash items | 127.00M | -171.00000M | -945.00000M | 1.00M | -9.00000M |
Free cash flow | -133.00000M | -142.00000M | -186.00000M | 85.00M | -84.00000M |
Sector: Industrials Industry: Specialty Industrial Machinery
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
AFGVY Agfa Gevaert NV ADR |
- -% | 1.33 | - | 12.39 | 0.09 | 0.29 | 0.21 | 3.75 |
SIEGY Siemens AG ADR |
2.93 2.63% | 114.16 | 17.07 | 15.75 | 1.88 | 2.76 | 2.37 | 11.38 |
SMAWF Siemens AG Class N |
2.40 1.08% | 224.30 | 16.98 | 15.53 | 1.83 | 2.72 | 2.35 | 11.32 |
GE GE Aerospace |
2.82 1.46% | 196.50 | 12.87 | 26.60 | 1.61 | 4.69 | 1.61 | 8.43 |
SBGSY Schneider Electric SA |
1.25 2.64% | 48.55 | 25.90 | 20.92 | 3.12 | 3.98 | 3.50 | 17.37 |
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company's CONOPS segment engages in supply of film and chemicals, as well support services. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. The company's Healthcare IT segment provides healthcare's enterprise imaging platform. Its Digital Print & Chemicals segment offers inkjet printers for sign and display and packaging printing companies; inkjet inks and fluids for industrial inkjet applications, such as signs, posters and displays, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry, as well as for printable synthetic papers. This segment also provides films for micrography, non-destructive testing, aerial photography and printed circuit board production; membranes for green hydrogen production; and conductive polymers and materials for the production of high-security ID documents. The company sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.
Septestraat 27, Mortsel, Belgium, 2640
Name | Title | Year Born |
---|---|---|
Mr. Pascal Juery | Pres, CEO, Pres of Radiology Solutions & Director | 1965 |
Mr. Dirk De Man | Chief Financial Officer | NA |
Mr. Wilfried Van Lishout | Compliance Officer & Company Sec. | 1964 |
Ms. Viviane Dictus | Director of Corp. Communications | NA |
Mr. Gunther Koch | Chief HR Officer | 1971 |
Mr. - Boyer | Exec. VP | NA |
Mr. Luc Delagaye | Pres of Offset Solutions | 1960 |
Mr. Vincent Wille | Pres of Digital Print & Chemicals | 1976 |
Jose Herraez | DR Global Head of Commerce | NA |
Mr. Scott Evers | Sr. VP & North American Bus. Leader | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.